Townsend John has filed 5 insider transactions across 1 company since August 2023.
Most recent transaction: a grant/award of 169500 shares of Unicycive Therapeutics, Inc. ($UNCY) on May 14, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | Unicycive Therapeutics, Inc. | $UNCY | Townsend John | CFO | A | Restricted Stock Unit | 169500 | $0.00 | 169,500.0000 | 23,908,153 | 9999.99% | 0.71% |
| July 28, 2025 | Unicycive Therapeutics, Inc. | $UNCY | Townsend John | Chief Financial Officer | A | Stock Options | 10000 | $0.00 | 101,557.0000 | 12,302,059 | 10.92% | 0.08% |
| Aug. 12, 2024 | Unicycive Therapeutics, Inc. | $UNCY | Townsend John | Chief Financial Officer | A | Stock Options | 40256 | $0.00 | 915,565.0000 | 9,405,285 | 4.60% | 0.43% |
| April 15, 2024 | Unicycive Therapeutics, Inc. | $UNCY | Townsend John | Chief Financial Officer | A | Stock Options | 228119 | $0.00 | 875,309.0000 | 34,912,692 | 35.25% | 0.65% |
| Aug. 28, 2023 | Unicycive Therapeutics, Inc. | $UNCY | Townsend John | Chief Financial Officer | A | Stock Options | 570329 | $0.00 | 647,190.0000 | 15,234,570 | 742.03% | 3.74% |